ENvue Medical, Inc. Goodwill & Intangibles Disclosure
Note 8 – GOODWILL
The following table presents the changes in the carrying amount of goodwill, all of which was recognized in connection with the ENvue Merger and relates to the ENvue reporting unit, for the years ended December 31, 2025 and 2024:
| Balance as of December 31, 2024 | $ | - | ||
| Acquisitions | 39,591 | |||
| Impairment | (10,509 | ) | ||
| Balance as of December 31, 2025 | $ | 29,082 |
For the years ended December 31, 2025 and 2024, the Company recorded goodwill impairment in the amounts of $10,509 and $0, respectively. See Note 21 for further information.
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.